BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Sareum notes Sierra Oncology Q1 2019 Results

  Sareum Holdings plc (AIM: SAR), the specialist small molecule drug development business, notes that Sierra Oncology (”Sierra”), the licence holder advancing clinical cancer candidate SRA737, has announced its results for the first quarter 2019.

  May 9, 2019

   · 

  4 min read
• New treatment could become first ever targeted therapy designed for ‘untreatable’ childhood brain cancer

  A new type of drug that targets a genetic weakness in an untreatable childhood brain cancer could become the first ever treatment designed to target the disease.

  May 9, 2019

   · 

  6 min read
• Sartorius Stedim Biotech Introduces New SIMCA® 16 Software for Multivariate Data Analytics

  Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical industry today announced the new SIMCA® 16 software for multivariate data analytics is available from its subsidiary Sartorius Stedim Data Analytics.

  May 9, 2019

   · 

  4 min read